REGULATORY INTELLIGENCE·Recall
Teva Pharmaceuticals Initiates Nationwide Class III Recall for Discolored Nortrel Oral Contraceptives
Teva Pharmaceuticals USA, Inc. has initiated a voluntary Class III nationwide recall for specific lots of its Nortrel (norethindrone and ethinyl estradiol) tablets due to discoloration. This event, impacting 12,916 cartons, highlights the critical need for robust quality control in pharmaceutical manufacturing and necessitates immediate supply chain assessment by procurement and regulatory teams to mitigate potential disruptions.
90-Day Activity